Here, we summarize and discuss the state of the art of the mechanisms involved in atherosclerosis (ATS), aging, and frailty, as relevant orchestrators of CVD, and the effects of LAV-BPIFB4 in these contexts. This evidence concerns the gene BPIFB4 and atherosclerosis.